60
Participants
Start Date
December 6, 2023
Primary Completion Date
August 31, 2027
Study Completion Date
August 31, 2027
Transcutaneous Spinal cord Stimulation
Delivered using a constant-current stimulator
Epidural Spinal Stimulation (ESS)
"The device used for ESS, the CoverEdgeX 32 Surgical Lead system (Boston Scientific, USA), is a device approved by the FDA used in the treatment of severe pain and is approved for individuals to manage chronic pain when other treatments have not been effective.~If you are in the ESS group, you will have surgery to have the stimulator placed and the stimulator will be removed at an office visit towards the end of the study."
RECRUITING
Houston Methodist Hospital, Houston
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
The Methodist Hospital Research Institute
OTHER